ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 56 filers reported holding ODONATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | 0.0% | 2,000 | +150.0% | 0.00% | – |
| Q1 2021 | $3,000 | -99.9% | 800 | -98.9% | 0.00% | – |
| Q2 2020 | $2,981,000 | -30.2% | 70,416 | -54.5% | 0.00% | -100.0% |
| Q1 2020 | $4,269,000 | -14.9% | 154,616 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,018,000 | -27.1% | 154,616 | -41.5% | 0.00% | 0.0% |
| Q3 2019 | $6,886,000 | -52.9% | 264,516 | -33.6% | 0.00% | -50.0% |
| Q2 2019 | $14,625,000 | +58.1% | 398,626 | -4.7% | 0.00% | +100.0% |
| Q1 2019 | $9,248,000 | +54.1% | 418,294 | -1.9% | 0.00% | 0.0% |
| Q4 2018 | $6,002,000 | -38.8% | 426,294 | -15.6% | 0.00% | 0.0% |
| Q3 2018 | $9,800,000 | -47.8% | 504,894 | -40.6% | 0.00% | -50.0% |
| Q2 2018 | $18,768,000 | +4.2% | 850,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $18,003,000 | -15.3% | 850,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,250,000 | – | 850,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $54,146,000 | 10.78% |
| Boxer Capital, LLC | 5,607,086 | $19,569,000 | 0.69% |
| Ikarian Capital, LLC | 1,986,412 | $6,933,000 | 0.56% |
| Samsara BioCapital, LLC | 700,421 | $2,444,000 | 0.30% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,680 | $652,000 | 0.29% |
| EcoR1 Capital, LLC | 831,200 | $2,901,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 113,360 | $396,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 230,794 | $805,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 41,210 | $144,000 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 81,180 | $283,000 | 0.02% |